Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02437318
Title Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. (SOLAR-1)
Acronym SOLAR-1
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUT | AUS

Facility Status City State Zip Country Details
Ironwood Cancer and Research Centers Chandler 2 Chandler Arizona 85224 United States Details
Mayo Clinic - Arizona Scottsdale Arizona 85259 United States Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Beverly Hills Cancer Center Beverly Hills California 90211 United States Details
City of Hope National Medical Center Duarte California 91010 3000 United States Details
Scripps Clinic SC La Jolla California 92037 United States Details
Kaiser Permanente - California Southern San Diego California 92120 United States Details
University of California San Francisco San Francisco California 94115 United States Details
Florida Cancer Specialists FL Cancer Specialists Fort Myers Florida 33901 United States Details
Florida Cancer Specialists-North SC Saint Petersburg Florida 33705 United States Details
Rush University Medical Center Rush Uni Medical Center Chicago Illinois 60612 United States Details
NorthShore University Health System NorthShore University Evanston Illinois 60201 United States Details
Edward Cancer Center SC Naperville Illinois 60540 United States Details
Fort Wayne Medical Oncology/Hematology, Inc. Dept.of Fort Wayne Med Onc/Hem Fort Wayne Indiana 46815 United States Details
St. Francis Health Comprehensive Cancer Center SC Topeka Kansas 66606-169 United States Details
Mercy Medical Center SC-2 Baltimore Maryland 21202 United States Details
Massachusetts General Hospital Updated Regulatory Boston Massachusetts 02114 United States Details
Lahey Clinic Burlington Massachusetts 01805 United States Details
Detroit Clinical Research Center Owosso Michigan 48867 United States Details
St. Luke's Cancer Institute SC Kansas City Missouri 64111 United States Details
St Vincent Frontier Cancer Center Billings Montana 59102 United States Details
Rutgers Cancer Institute of New Jersey SC-2 New Brunswick New Jersey 08903 United States Details
University Hospitals of Cleveland Seidman Cancer Center SC Cleveland Ohio 44106 United States Details
Good Samaritan Regional Medical Center Good Samaritan Reg Med Ctr Corvallis Oregon 97330 United States Details
Lancaster General Hospital Lancaster Pennsylvania 17604 United States Details
Prisma Health Upstate SC-2 Greenville South Carolina 29615 United States Details
Avera Cancer SC Sioux Falls South Dakota 57105 United States Details
Tennessee Oncology SC-3 Nashville Tennessee 37203 United States Details
Texas Oncology PA Dallas Presbyterian Hospital SC-1 Dallas Texas 75231 United States Details
El Paso, Texas Oncology El Paso Texas 79902 United States Details
Mays Cancer Ctr Uthsa Mdacc InstituteForDrugDevelopment(4) San Antonio Texas 78229 United States Details
Texas Oncology Northeast Texas Tyler Texas 75702 United States Details
Virginia Cancer Specialists SC Fairfax Virginia 22031 United States Details
Wenatchee Valley Medical Center SC-2 Wenatchee Washington 98801 United States Details
Novartis Investigative Site Berazategui Buenos Aires B1884BBF Argentina Details
Novartis Investigative Site Caba Buenos Aires C1125ABD Argentina Details
Novartis Investigative Site Rio Negro Viedma 8500 Argentina Details
Novartis Investigative Site La Rioja 5300 Argentina Details
Novartis Investigative Site Wahroonga New South Wales 2076 Australia Details
Novartis Investigative Site Wooloongabba Queensland 4102 Australia Details
Novartis Investigative Site Elizabeth Vale South Australia 5112 Australia Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Linz 4010 Austria Details
Novartis Investigative Site Vienna 1090 Austria Details
Novartis Investigative Site Edegem Antwerpen 2650 Belgium Details
Novartis Investigative Site Jette Brussel 1090 Belgium Details
Novartis Investigative Site Sint Niklaas Oost Vlaanderen 9100 Belgium Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Libramont 6800 Belgium Details
Novartis Investigative Site Ottignies 1340 Belgium Details
Novartis Investigative Site Verviers 4800 Belgium Details
Novartis Investigative Site Natal RN 59075 740 Brazil Details
Novartis Investigative Site Lajeado RS 95900-000 Brazil Details
Novartis Investigative Site Sao Paulo SP 04014-002 Brazil Details
Novartis Investigative Site Sao Jose do Rio Preto 15090 000 Brazil Details
Novartis Investigative Site Sao Paulo 01236 030 Brazil Details
Novartis Investigative Site Plovdiv 4004 Bulgaria Details
Novartis Investigative Site Sofia 1756 Bulgaria Details
Novartis Investigative Site Varna 9002 Bulgaria Details
Novartis Investigative Site Varna 9010 Bulgaria Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Cambridge Ontario N1R 3G2 Canada Details
Novartis Investigative Site Ottawa Ontario KIH 7W9 Canada Details
Novartis Investigative Site Toronto Ontario M5B 1W8 Canada Details
Novartis Investigative Site Quebec G1S 4L8 Canada Details
Novartis Investigative Site Temuco Araucania 4810469 Chile Details
Novartis Investigative Site Santiago 8420383 Chile Details
Novartis Investigative Site Vina del Mar 2520612 Chile Details
Novartis Investigative Site Hradec Kralove Czech Republic 500 05 Czechia Details
Novartis Investigative Site Praha 4 Czech Republic 140 46 Czechia Details
Novartis Investigative Site Zlin Czech Republic 762 75 Czechia Details
Novartis Investigative Site Prague 8 180 00 Czechia Details
Novartis Investigative Site Marseille cedex 20 Bouches Du Rhone 13915 France Details
Novartis Investigative Site Angers 02 49055 France Details
Novartis Investigative Site Avignon 84082 France Details
Novartis Investigative Site Caen 14021 France Details
Novartis Investigative Site Clermont Ferrand 63011 France Details
Novartis Investigative Site Creteil 94010 France Details
Novartis Investigative Site La Roche sur Yon cedex 9 85925 France Details
Novartis Investigative Site Le Chesnay 78157 France Details
Novartis Investigative Site Levallois-Perret 92309 France Details
Novartis Investigative Site Lyon Cedex 08 69373 France Details
Novartis Investigative Site Montpellier 34070 France Details
Novartis Investigative Site Nimes 30029 France Details
Novartis Investigative Site Rouen 76038 France Details
Novartis Investigative Site Saint-Herblain Cédex 44805 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Villejuif Cedex 94800 France Details
Novartis Investigative Site Recklinghausen North Rhine-westphalia 45657 Germany Details
Novartis Investigative Site Leipzig Sachsen 04277 Germany Details
Novartis Investigative Site Luebeck Schleswig-Holstein 23563 Germany Details
Novartis Investigative Site Aschaffenburg 63739 Germany Details
Novartis Investigative Site Frankfurt 60389 Germany Details
Novartis Investigative Site Friedrichshafen 88045 Germany Details
Novartis Investigative Site Hannover 30625 Germany Details
Novartis Investigative Site Homburg 66421 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Potsdam 14467 Germany Details
Novartis Investigative Site Rostock 18059 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Velbert 42551 Germany Details
Novartis Investigative Site Thessaloniki GR 564 29 Greece Details
Novartis Investigative Site Athens 115 28 Greece Details
Novartis Investigative Site Athens 18547 Greece Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Budapest 1134 Hungary Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Nyiregyhaza 4400 Hungary Details
Novartis Investigative Site Szekszard 7100 Hungary Details
Novartis Investigative Site Vijayawada Andhra Pradesh 520002 India Details
Novartis Investigative Site Nagpur - Maharashtra Maharashtra 440010 India Details
Novartis Investigative Site Mumbai 400 012 India Details
Novartis Investigative Site Beer-Sheva 8457108 Israel Details
Novartis Investigative Site Haifa 3109601 Israel Details
Novartis Investigative Site Petach Tikva 4941492 Israel Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Chieti CH 66100 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Palermo PA 90127 Italy Details
Novartis Investigative Site Padova PD 35100 Italy Details
Novartis Investigative Site Pontedera PI 56025 Italy Details
Novartis Investigative Site Aviano PN 33081 Italy Details
Novartis Investigative Site Rionero in Vulture PZ 85028 Italy Details
Novartis Investigative Site Roma RM 00155 Italy Details
Novartis Investigative Site Sassari SS 07100 Italy Details
Novartis Investigative Site Savona SV 17100 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Negrar VR 37024 Italy Details
Novartis Investigative Site Nagoya Aichi 464 8681 Japan Details
Novartis Investigative Site Matsuyama Ehime 791-0280 Japan Details
Novartis Investigative Site Maebashi city Gunma 371 8511 Japan Details
Novartis Investigative Site Sapporo-city Hokkaido 003-0804 Japan Details
Novartis Investigative Site Akashi Hyogo 673-8558 Japan Details
Novartis Investigative Site Kagoshima-city Kagoshima 892-0833 Japan Details
Novartis Investigative Site Isehara Kanagawa 259-1193 Japan Details
Novartis Investigative Site Yokohama-city Kanagawa 241-8515 Japan Details
Novartis Investigative Site Kumamoto City Kumamoto 860-8556 Japan Details
Novartis Investigative Site Osaka-city Osaka 540-0006 Japan Details
Novartis Investigative Site Osaka-city Osaka 541-8567 Japan Details
Novartis Investigative Site Kitaadachi-gun Saitama 362-0806 Japan Details
Novartis Investigative Site Chuo ku Tokyo 104-8560 Japan Details
Novartis Investigative Site Minato ku Tokyo 105-8470 Japan Details
Novartis Investigative Site Bundang Gu Gyeonggi Do 13620 Korea, Republic of Details
Novartis Investigative Site Gyeonggi do Korea 10408 Korea, Republic of Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Beirut 10999 Lebanon Details
Novartis Investigative Site Saida 652 Lebanon Details
Novartis Investigative Site Monterrey NL Monterrey 64320 Mexico Details
Novartis Investigative Site San Luis Potosi 78200 Mexico Details
Novartis Investigative Site Venray CE 5801 Netherlands Details
Novartis Investigative Site Terneuzen 4535 PA Netherlands Details
Novartis Investigative Site San Borja Lima 41 Peru Details
Novartis Investigative Site Surquillo Lima 34 Peru Details
Novartis Investigative Site Lima LIMA 27 Peru Details
Novartis Investigative Site Floresti Cluj 407280 Romania Details
Novartis Investigative Site Craiova Dolj 200347 Romania Details
Novartis Investigative Site Iasi 700483 Romania Details
Novartis Investigative Site Arkhangelsk 163045 Russian Federation Details
Novartis Investigative Site Ryazan 390011 Russian Federation Details
Novartis Investigative Site St Petersburg 197758 Russian Federation Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Jerez Cadiz 11407 Spain Details
Novartis Investigative Site Barcelona Cataluna 08024 Spain Details
Novartis Investigative Site Badalona Catalunya 08916 Spain Details
Novartis Investigative Site Alicante Comunidad Valenciana 03010 Spain Details
Novartis Investigative Site Castellon Comunidad Valenciana 12002 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Badajoz Extremadura 06080 Spain Details
Novartis Investigative Site Caceres Extremadura 10003 Spain Details
Novartis Investigative Site Santiago de Compostela Galicia 15706 Spain Details
Novartis Investigative Site Palma De Mallorca Islas Baleares 07120 Spain Details
Novartis Investigative Site Pozuelo de Alarcon Madrid 28223 Spain Details
Novartis Investigative Site El Palmar Murcia 30120 Spain Details
Novartis Investigative Site La Laguna Santa Cruz De Tenerife 38320 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Gavle SE-801 87 Sweden Details
Novartis Investigative Site Oerebro 70185 Sweden Details
Novartis Investigative Site Vasteras 721 89 Sweden Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taipei 11217 Taiwan Details
Novartis Investigative Site Bangkok THA 10330 Thailand Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Plymouth Devon PL6 8DH United Kingdom Details
Novartis Investigative Site Leicester LE1 5WW United Kingdom Details
Novartis Investigative Site London SE1 9RT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field